Tag: Covid-19
Browse our exclusive articles!
Diplomacy in Disarray: Rethinking India’s Narrative in the Face of Pakistan’s Propaganda Offensive
In the battlefield of geopolitics, words are weapons, narratives...
Pakistan’s Strategic Crypto Gambit: A New War Room for National Interest
In a striking departure from traditional geopolitical maneuvering, Pakistan...
Strategic Adaptation of Armoured Warfare in the Precision Era: Integrating Technology, Doctrine, and Deterrence
India is currently at a critical juncture, necessitating a...
The Neck or the Noose: India’s Diplomatic Arsenal to Counter Bangladesh’s Strategic Drift
In the realm of statecraft, there are instances where...
COVID-19 vaccines in clinical trials but scientists clueless on antibody
Using X-ray crystallography, the team imaged two antibodies attached to their target site on SARS-CoV-2 and the resulting atomic-structure details of this interaction might potentially help the vaccine designers.
US withdrawal from WHO draws scepticism and criticisms
The US contributes between $107 to $119 million in assessed contributions and an additional $102 - $401 million per year. The WHO’s total budget per year is $2.4 billion.
PFRDA allows Upgrade or Downgrade of Atal Pension Yojana Account round the year
Earlier, this provision was available only during the month of April every year. Effective from July 1, this is with a view to make the Atal Pension Yojana more attractive for its 2.28 crore subscribers.
Use Clause 92 of the Indian Patent Act, break Remdesivir monopoly, issue Compulsory License
India is one of the largest generic drug manufacturers in the world and there should be no reason why Remdesivir and other COVID-19 drugs cannot be made available rapidly and at affordable prices to India and the world.
My Doctor wife shows how to beat COVID 19 like a boss
Covid19 was declared a pandemic in the first quarter of 2020. Everyone’s lives changed. We, the doctors who were looked down upon by the...